Table 2.
Outcome | Risk period | Events (n) | Person-time (days) | Incidence rate ratio (95% CI) | P values |
Vasculitis |
Unexposed | 89 | 30 936 | 1.00 | 0.906 |
15 days prevaccination | 5 | 1815 | 0.95 (0.38 to 2.33) | ||
Postvaccination intervals | |||||
0–14 days | X1 | 1694 | 0.41 (0.10 to 1.65) | 0.207 | |
15–30 days | 5 | 1815 | 0.95 (0.38 to 2.33) | 0.906 | |
31–60 days | 8 | 3630 | 0.76 (0.37 to 1.56) | 0.453 | |
61–90 days | 12 | 3630 | 1.14 (0.62 to 2.08) | 0.677 | |
Unexplained | Unexposed | 92 | 30 735 | 1.00 | 0.507 |
Fever |
15 days prevaccination | X1 | 1819 | 0.71 (0.26 to 1.94) | |
Postvaccination intervals | |||||
0–14 days | X1 | 1708 | 0.71 (0.26 to 1.94) | 0.589 | |
15–30 days | 6 | 1830 | 1.06 (0.28 to 2.07) | 0.887 | |
31–60 days | 5 | 3650 | 0.45 (0.18 to 1.10) | 0.079 | |
61–90 days | 12 | 3630 | 1.09 (0.60 to 1.99) | 0.780 |
X1 fewer than five events in each cell, data suppressed according to Clinical Practice Research Datalink policy.
*Unexplained fever was defined as fever not due to a known cause, for example, infection.